India Single Cell Analysis Market Size & Outlook, 2026-2033
The single cell analysis market in India is expected to reach a projected revenue of US$ 754.0 million by 2033. A compound annual growth rate of 23.15% is expected of India single cell analysis market from 2026 to 2033.
In terms of revenue, India accounted for 2.7% of the global single cell analysis market in 2025.
Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
In Asia Pacific, China single cell analysis market is projected to lead the regional market in terms of revenue in 2033.
Japan is the fastest growing regional market in Asia Pacific and is projected to reach USD 870.5 million by 2033.
In the biotechnology sector, India is currently ranked 12th in the world and 3rd in the Asia Pacific region, and it is still the world's largest manufacturer of vaccines. In addition, under the Pradhan Mantri Aatma nirbhar Swasth Bharat Yojana in March 2021, the government planned to establish nine biosafety-level-3 laboratories.
The Department of Biotechnology set up biotech parks and incubators nationwide to provide infrastructure support while converting research into products, in November 2023. In addition, the market is majorly driven by the application of single-cell analysis in the healthcare sector, which majorly includes recombinant therapeutics and vaccines.
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Single Cell Analysis Market Outlook will help companies and investors design strategic landscapes.
Consumables was the largest segment with a revenue share of 64.37% in 2025.
Horizon Databook has segmented the India single cell analysis market based on instruments, consumables covering the revenue growth of each sub-segment from 2021 to 2033.
In the biotechnology sector, India is currently ranked 12th in the world and 3rd in the Asia Pacific region, and it is still the world's largest manufacturer of vaccines. In addition, under the Pradhan Mantri Aatma nirbhar Swasth Bharat Yojana in March 2021, the government planned to establish nine biosafety-level-3 laboratories.
The Department of Biotechnology set up biotech parks and incubators nationwide to provide infrastructure support while converting research into products, in November 2023. In addition, the market is majorly driven by the application of single-cell analysis in the healthcare sector, which majorly includes recombinant therapeutics and vaccines.
India Single Cell Analysis Market Product Outlook (Revenue, USD Million , 2021-2033)
Consumables
Instruments
India Single Cell Analysis Market Application Outlook (Revenue, USD Million , 2021-2033)
Cancer
Immunology
Neurology
Stem Cell
Non invasive prenatal diagnosis
In vitro Fertilisation
Other Application
India Single Cell Analysis Market Workflow Outlook (Revenue, USD Million , 2021-2033)
Single Cell Isolation & Library Preparation
Downstream Analysis
Data Analysis
India Single Cell Analysis Market End Use Outlook (Revenue, USD Million , 2021-2033)
Academic & Research Laboratories
Biotechnology and Pharmaceutical Companies
Hospitals and Diagnostic Laboratories
Other End Use
Reasons to subscribe to Single Cell Analysis Market Outlook databook
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Single Cell Analysis Market Outlook databook
Our clientele includes a mix of Single Cell Analysis Market Outlook companies, investment firms, advisory firms & academic institutions.
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the India Single Cell Analysis Market Outlook, including forecasts for subscribers. This country databook contains high-level insights into India Single Cell Analysis Market Outlook from 2021 to 2033, including revenue numbers, major trends, and company profiles.
India Single Cell Analysis Market, 2021-2033 (US$M)